TCL Archive Groups Urge FDA To Take Action Against Tobacco Products By Cancer History Project June 27, 2014
TCL Archive Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy By Cancer History Project June 27, 2014
TCL Archive Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC By Cancer History Project June 27, 2014
TCL Archive FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC By Cancer History Project June 27, 2014
TCL Archive Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III By Cancer History Project June 27, 2014
TCL Archive Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint By Cancer History Project June 27, 2014
TCL Archive Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months By Cancer History Project June 27, 2014
Research Milestone How a database stretching back to the 1970s leads to new findings about blood cell mutations By Fred Hutch
